Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
- PMID: 32688380
- PMCID: PMC7454510
- DOI: 10.1093/eurheartj/ehaa509
Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
Figures
Comment in
-
Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?Eur Heart J. 2020 Jul 1;41(32):3094. doi: 10.1093/eurheartj/ehaa576. Eur Heart J. 2020. PMID: 32699894 Free PMC article. No abstract available.
Comment on
-
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.Eur Heart J. 2020 May 14;41(19):1821-1829. doi: 10.1093/eurheartj/ehaa388. Eur Heart J. 2020. PMID: 32383763 Free PMC article.
References
-
- Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M.. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 2020;41:1821–1829. - PMC - PubMed
-
- Characteristics of COVID-19 patients dying in Italy. Report based on available data on April 6th, 2020. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019... (8 April 2020).
-
- New York State Department of Health. https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOV... (30 April 2020).
-
- Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM.. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace 2017;19:1280–1287. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical